Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo). 2012;67(6):565-72. doi: 10.6061/clinics/2012(06)04.
This study evaluated the effect of Continuous Positive Airway Pressure treatment on oxidative stress parameters and the quality of life of elderly patients with obstructive sleep apnea syndrome.
In total, 30 obstructive sleep apnea syndrome patients and 27 subjects without obstructive sleep apnea syndrome were included in this study. Both groups underwent quality of life and oxidative stress evaluations at baseline and after six months. Polysomnography was performed in both groups at baseline and a second time in the obstructive sleep apnea syndrome group after six months of Continuous Positive Airway Pressure treatment. All of the variables were compared between the control and obstructive sleep apnea syndrome groups in this prospective case-control study.
The baseline concentrations of the antioxidant enzyme catalase were higher in the obstructive sleep apnea syndrome group than the control group. After Continuous Positive Airway Pressure treatment, the obstructive sleep apnea syndrome group exhibited a reduction in the level of oxidative stress, as indicated by a decrease in the level of lipid peroxidation measured by the malondialdehyde (MDA) concentration [pre: 2.7 nmol malondialdehyde/mL (95% 1.6-3.7) vs. post: 1.3 nmol MDA/mL (0.7-1.9), p<0.01]. Additionally, improvements were observed in two domains covered by the SF-36 questionnaire: functional capacity [pre: 77.4 (69.2-85.5) vs. post: 83.4 (76.9-89.9), p = 0.002] and pain [pre: 65.4 (52.8-78.1) vs. post: 77.8 (67.2-88.3), p = 0.004].
Our study demonstrated that the use of Continuous Positive Airway Pressure to treat obstructive sleep apnea syndrome in elderly patients reduced oxidative stress and improved the quality of life.
本研究评估持续气道正压通气治疗对老年阻塞性睡眠呼吸暂停综合征患者氧化应激参数和生活质量的影响。
共纳入 30 例阻塞性睡眠呼吸暂停综合征患者和 27 例无阻塞性睡眠呼吸暂停综合征患者。两组患者在基线和 6 个月时均进行生活质量和氧化应激评估。两组患者均在基线时进行多导睡眠图检查,阻塞性睡眠呼吸暂停综合征组在 6 个月持续气道正压通气治疗后进行第二次检查。在这项前瞻性病例对照研究中,将所有变量与对照组和阻塞性睡眠呼吸暂停综合征组进行比较。
阻塞性睡眠呼吸暂停综合征组的抗氧化酶过氧化氢酶基线浓度高于对照组。持续气道正压通气治疗后,阻塞性睡眠呼吸暂停综合征组的氧化应激水平降低,丙二醛(MDA)浓度测定的脂质过氧化水平降低[治疗前:2.7 nmol MDA/mL(95%置信区间:1.6-3.7)vs. 治疗后:1.3 nmol MDA/mL(0.7-1.9),p<0.01]。此外,SF-36 问卷涵盖的两个领域的情况有所改善:功能能力[治疗前:77.4(69.2-85.5)vs. 治疗后:83.4(76.9-89.9),p=0.002]和疼痛[治疗前:65.4(52.8-78.1)vs. 治疗后:77.8(67.2-88.3),p=0.004]。
我们的研究表明,使用持续气道正压通气治疗老年阻塞性睡眠呼吸暂停综合征可降低氧化应激,改善生活质量。